Literature DB >> 17147875

[The clinical features of postoperative ventilator-associated pneumonia after lung surgery].

Xing-an Wang1, Wen-pu Tong, Ge-ning Jiang, Jia-an Ding, Yi-ming Zhou.   

Abstract

OBJECTIVE: To investigate the clinical features of postoperative ventilator-associated pneumonia (VAP) after lung surgery.
METHODS: Of 104 patients who had undergone lung surgery and been treated with ventilator in our surgical intensive care unit between January 2003 and March 2005, 35 patients met with the criteria of both VAP and postoperative pneumonia (POP), and 41 cases had no evidences of pneumonia. The clinical and laboratory data of all 76 cases were recorded and analyzed by a statistical software package (SPSS).
RESULTS: The diagnosis of postoperative VAP was established clinically in 35 patients (46.1%), and etiologically in 33 cases. Compared to the patients without postoperative VAP, the patients with postoperative VAP had a significantly longer mean interval between intubation and operation [(2.7 +/- 2.9) days vs. (1.6 +/- 1.7) days, P = 0.039], a longer duration of mechanical ventilation [(32.2 +/- 37.7) days vs. (4.2 +/- 2.9) days, P < 0.001], and higher morbidity (20.0% vs. 2.4%, P = 0.013). There was a significant difference in mean duration of mechanical ventilation between the 15 cases of early-onset VAP and 20 cases of late-onset VAP (17 +/- 15 days vs. 43 +/- 46 days, P = 0.042). Among the initially detected pathogen, Staphylococcus aureus remains the most common Gram-positive coccus whereas Acinetobacter Baumannii took the place of Pseudomonas aeruginosa as the top Gram-negative rod.
CONCLUSION: Postoperative VAP after lung surgery has different clinical features from VAP in medical ICU.

Entities:  

Mesh:

Year:  2006        PMID: 17147875

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  1 in total

1.  Nonintubated thoracoscopic lung resection: a 3-year experience with 285 cases in a single institution.

Authors:  Ke-Cheng Chen; Ya-Jung Cheng; Ming-Hui Hung; Yu-Ding Tseng; Jin-Shing Chen
Journal:  J Thorac Dis       Date:  2012-08       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.